eli lilly & co (LLY:EN Paris)
Transactions by ELI LILLY & CO (LLY) in the last 6 months
Immunocore Limited announced that it has received £205 million in its series A round of funding led by new investor, Malin Corporation plc on July 16, 2015. The oversubscribed transaction included participation from other new investors, Woodford Investment Management LLP, Eli Lilly and Company and RTW Investments, LLC and other new and existing investors. Malin Corporation plc invested £51,170,200 ($80,000,000) in the transaction. As part of the transaction, Adrian Howd, ...
Malin Corporation plc
RTW Investments, LLC
Woodford Investment Management LLP
Companion Medical, Inc. announced that it will receive $3,500,000 in equity funding on May 14, 2015. The company will issue securities pursuant to exemption provided under Regulation D.
On May 20, 2015, the company received $3,170,000 in first tranche in its series B round of funding led by new investor Eli Lilly and Company. The round included participation from three investors. As a part of the round, one representative of Eli Lilly and Company will join the company’s ...
Cell & Gene GmbH announced that it will receive $30 million in equity funding from new investor, Eli Lilly and Company on May 11, 2015. Jochen of Freshfields Bruckhaus Deringer acted as a legal advisor to the company.
|Abbott Laboratories||$50.69 USD||-0.08|
|AbbVie Inc||$70.01 USD||-0.15|
|Bristol-Myers Squibb Co||$65.64 USD||+1.18|
|Medtronic PLC||$78.39 USD||+0.11|
|Teva Pharmaceutical Industries Ltd||$69.02 USD||-0.05|
|View Industry Companies|